| Literature DB >> 30568041 |
Clément Jacquemin1, Jean-François Augusto2, Marc Scherlinger2,3, Noémie Gensous2, Edouard Forcade2, Isabelle Douchet2, Emeline Levionnois2, Christophe Richez2,3, Estibaliz Lazaro2,3, Pierre Duffau2,3, Marie-Elise Truchetet2,3, Julien Seneschal1,3, Lionel Couzi3, Jean-Luc Pellegrin3, Jean-François Viallard3, Thierry Schaeverbeke3, Virginia Pascual4, Cécile Contin-Bordes2,3, Patrick Blanco2,3.
Abstract
Tregs are impaired in human systemic lupus erythematosus (SLE) and contribute to effector T cell activation. However, the mechanisms responsible for the Treg deficiency in SLE remain unclear. We hypothesized that the OX40L/OX40 axis is implicated in Treg and regulatory follicular helper T (Tfr) cell dysfunction in human SLE. OX40L/OX40 axis engagement on Tregs and Tfr cells not only specifically impaired their ability to regulate effector T cell proliferation, but also their ability to suppress T follicular helper (Tfh) cell-dependent B cell activation and immunoglobulin secretion. Antigen-presenting cells from patients with active SLE mediated Treg dysfunction in an OX40L-dependent manner, and OX40L-expressing cells colocalized with Foxp3+ cells in active SLE skin lesions. Engagement of the OX40L/OX40 axis resulted in Foxp3 downregulation in Tregs, and expression in SLE Tregs correlated with the proportion of circulating OX40L-expressing myeloid DCs. These data support that OX40L/OX40 signals are implicated in Treg dysfunction in human SLE. Thus, blocking the OX40L/OX40 axis appears to be a promising therapeutic strategy.Entities:
Keywords: Autoimmune diseases; Autoimmunity; Cellular immune response; Immunology; Lupus
Mesh:
Substances:
Year: 2018 PMID: 30568041 PMCID: PMC6338386 DOI: 10.1172/jci.insight.122167
Source DB: PubMed Journal: JCI Insight ISSN: 2379-3708